Antonio Frassoldati

Antonio Frassoldati

UNVERIFIED PROFILE

Are you Antonio Frassoldati?   Register this Author

Register author
Antonio Frassoldati

Antonio Frassoldati

Publications by authors named "Antonio Frassoldati"

Are you Antonio Frassoldati?   Register this Author

63Publications

1273Reads

11Profile Views

HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.

Clin Breast Cancer 2018 10 18;18(5):e1133-e1139. Epub 2018 Apr 18.

Division of Clinical Oncology, St Anna University Hospital, Ferrara, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.04.006DOI Listing
October 2018

Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study.

Eur J Cardiothorac Surg 2018 06;53(6):1199-1204

Department of Morfology, Experimental Medicine and Surgery, Section of General and Thoracic Surgery, Azienda Ospedaliero Universitaria di Ferrara Arcispedale Sant'Anna, Ferrara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ejcts/ezx464DOI Listing
June 2018

Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study.

Eur J Cancer Prev 2017 01;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S56-S62

aDepartment of Public Health, Area Vasta Emilia Centrale Cancer Registry, Ferrara Local Health Unit bDepartment of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara cDepartment of Public Health, Area Vasta Emilia Centrale Cancer Registry, Bologna Local Health Unit, Bologna dClinical Oncology Unit, Department of Specialty Medicine, University Hospital Ferrara, Ferrara, Italy eDepartment of Biostatistics, University Hospital of Lyon fUniversity of Lyon, Lyon gUniversity of Lyon 1 hCNRS, UMR 5558,Biometry and Evolutionary Biology Laboratory (LBBE), BioMaths-Health Department iFrench Network of Cancer Registries (Francim), Toulouse jBas-Rhin Cancer Registry, Department of Epidemiology and Public Health, EA 3430, Faculty of Medicine, University of Strasbourg kDepartment of Public Health, University Hospital of Strasbourg, Strasbourg lRegistre Bourguignon des Cancers Digestifs, CHU de Dijon; INSERM U 866; University of Burgundy, Dijon, France mRegistro Tumori del Canton Ticino, Istituto cantonale di patologia, Locarno, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CEJ.0000000000000298DOI Listing
January 2017

Current views on anthracycline cardiotoxicity.

Heart Fail Rev 2016 09;21(5):621-34

Department of Medical Sciences "Mario Aresu", University of Cagliari, Cagliari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10741-016-9564-5DOI Listing
September 2016

Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologists.

Future Oncol 2015 ;11(8):1181-9

UO Oncologia Medica, Azienda Ospedaliera Treviglio, Treviglio BG, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.289DOI Listing
February 2016

Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients.

Ultrasound Med Biol 2016 Jan 24;42(1):125-32. Epub 2015 Oct 24.

Department of Cardiology and LTTA Center, University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ultrasmedbio.2015.09.008DOI Listing
January 2016

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer.

Oncologist 2015 Sep 5;20(9):1001-10. Epub 2015 Aug 5.

Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Division of Medical Oncology 2, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy; Division of Oncology, University Hospital, Ferrara, Italy; Division of Pathology, Modena University Hospital, Modena, Italy; Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy; Unità Operativa Multidisciplinare di Patologia Mammaria, Azienda Ospedaliera Istituti Ospitalieri di Cremona, Cremona, Italy; Division of Medical Oncology, Ramazzini Hospital, Carpi, Italy; Department of Medical Oncology, Azienda Ospedaliera ASMN, IRCCS, Reggio Emilia, Italy; Division of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy; Division of Medical Oncology, University Hospital, Parma, Italy; GlaxoSmithKline, Collegeville, Pennsylvania, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571802PMC
September 2015

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

Am J Case Rep 2015 Jul 3;16:424-9. Epub 2015 Jul 3.

Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/AJCR.893879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492486PMC
July 2015

Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.

Biomark Res 2015 6;3:12. Epub 2015 Jun 6.

Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Via Luigi Borsari, 46, 44121 Ferrara, Italy ; Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40364-015-0037-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483205PMC
June 2015

Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.

J Clin Oncol 2014 Apr 3;32(10):1050-7. Epub 2014 Mar 3.

Valentina Guarneri and PierFranco Conte, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Padova, Padova; Daniele Giulio Generali and Alberto Bottini, U.O. Multidisciplinare di Patologia Mammaria, Azienda Ospedaliera Istituti Ospitalieri di Cremona, Cremona; Antonio Frassoldati, University Hospital, Ferrara; Fabrizio Artioli and Katia Cagossi, Ramazzini Hospital, Carpi; Corrado Boni and Giancarlo Bisagni, Azienda Ospedaliera Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia; Luigi Cavanna, Hospital of Piacenza, Piacenza; Enrico Tagliafico, Enrica Roncaglia, and Simona Nuzzo, Center for Genome Research, University of Modena and Reggio Emilia; Antonino Maiorana, Federico Piacentini, Guido Ficarra, and Stefania Bettelli, Modena University Hospital, Modena, Italy; Ramona Swaby and Catherine Ellis, GlaxoSmithKline, Upper Providence, PA; and Clare Holford, GlaxoSmithKline, Stockley Park, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4737DOI Listing
April 2014

Synchronous papillary carcinoma and hemangiopericytoma with lung metastases.

Case Rep Otolaryngol 2013 4;2013:231758. Epub 2013 Dec 4.

Department of Otolaringology, Azienda Ospedaliero-Universitaria St. Anna di Ferrara, Via A. Moro 8, 44124 Cona (Ferrara), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/231758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867875PMC
December 2013

Gastrointestinal stromal tumors and other malignancies: a case series.

J Gastrointest Cancer 2012 Dec;43(4):634-7

Clinical Oncology Unit, St. Anna University-Hospital, Ferrara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12029-012-9371-8DOI Listing
December 2012

Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma.

J Clin Oncol 2012 Feb 27;30(6):e76-8. Epub 2011 Dec 27.

Department of Oncology, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia Hospital, via del Pozzo 71, 41124 Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.38.7886DOI Listing
February 2012

[Oncological quality indicators and Colorectal Cancer Program: data from 2009-2010 of University Hospital in Ferrara, Italy].

Recenti Prog Med 2012 Feb;103(2):56-61

Unità Operativa Oncologia, Azienda Ospedaliero-Universitaria, Ferrara.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1701/1045.11386DOI Listing
February 2012

The clinical relevance of endocrine-therapy-induced changes in lipid metabolism in breast cancer patients.

Cancer Biol Ther 2009 Aug 5;8(15):1456-8. Epub 2009 Aug 5.

Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.8.15.9186DOI Listing
August 2009

Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer.

Breast Cancer Res Treat 2009 May 13;115(1):131-6. Epub 2008 Sep 13.

National Cancer Research Institute, Genoa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0048-8DOI Listing
May 2009

Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial).

Clin Breast Cancer 2008 Apr;8(2):192-4

Division of Medical Oncology, Department of Oncology and Hematology, University Hospital, University of Modena and Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2008.n.022DOI Listing
April 2008

Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB).

Clin Breast Cancer 2008 Feb;8(1):97-100

Division of Medical Oncology, Department of Oncology and Hematology, University Hospital, University of Modena and Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2008.n.010DOI Listing
February 2008

Primary systemic therapy for operable breast cancer: a review of clinical trials and perspectives.

Cancer Lett 2007 Apr 21;248(2):175-85. Epub 2006 Aug 21.

Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2006.07.001DOI Listing
April 2007

Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective.

Breast J 2007 Jan-Feb;13(1):28-35

Department of Oncology and Hematology, The University of Modena and Reggio Emilia, Modena, Italy. conte.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1524-4741.2006.00359.x
Publisher Site
http://dx.doi.org/10.1111/j.1524-4741.2006.00359.xDOI Listing
March 2007

Predictive value of biologic parameters for primary chemotherapy in operable breast cancer.

Clin Breast Cancer 2005 Oct;6(4):315-24

Division of Medical Oncology, Department of Oncology and Hematology, University of Modena, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152682091170858
Publisher Site
http://dx.doi.org/10.3816/CBC.2005.n.034DOI Listing
October 2005